Literature DB >> 27516116

Late-Life Vascular Risk Factors and Alzheimer Disease Neuropathology in Individuals with Normal Cognition.

Lilah M Besser1, Michael L Alosco2, Liliana Ramirez Gomez2, Xiao-Hua Zhou2, Ann C McKee2, Robert A Stern2, John Gunstad2, Julie A Schneider2, Helena Chui2, Walter A Kukull2.   

Abstract

Vascular risk factors (VRFs) have been associated with clinically diagnosed Alzheimer disease (AD), but few studies have examined the association between VRF and AD neuropathology (ADNP) in cognitively normal individuals. We used longitudinal data from the National Alzheimer's Disease Center's Uniform Data Set and Neuropathology Data Set to examine the association between VRF and ADNP (moderate to frequent neuritic plaques; Braak stage III-VI) in those with normal cognition. Our sample included 53 participants with ADNP and 140 without ADNP. Body mass index (BMI), resting heart rate (HR), and pulse pressure (PP) were measured at each visit; values were averaged across participant visits and examined annual change in BMI, PP, and HR. Hypertension, diabetes, and hypercholesterolemia were self-reported. In the multivariable logistic regression analyses, average BMI and HR were associated with lower odds of ADNP, and annual increases in HR and BMI were associated with higher odds of ADNP. A previously experienced decline in BMI or HR in late-life (therefore, currently low BMI and low HR) as well as a late-life increase in BMI and HR may indicate underlying AD pathology. Additional clinicopathological research is needed to elucidate the role of changes in late-life VRF and AD pathogenesis.
© 2016 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Asymptomatic; Body mass index; Heart rate; Neuropathology; Normal cognition; Vascular risk factor.

Year:  2016        PMID: 27516116      PMCID: PMC5029440          DOI: 10.1093/jnen/nlw072

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  63 in total

1.  Midlife blood pressure and dementia: the Honolulu-Asia aging study.

Authors:  L J Launer; G W Ross; H Petrovitch; K Masaki; D Foley; L R White; R J Havlik
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

2.  Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort.

Authors:  Adam M Brickman; Christiane Reitz; José A Luchsinger; Jennifer J Manly; Nicole Schupf; Jordan Muraskin; Charles DeCarli; Truman R Brown; Richard Mayeux
Journal:  Arch Neurol       Date:  2010-05

3.  Unstable Body Mass Index and Progression to Probable Alzheimer's Disease Dementia in Patients with Amnestic Mild Cognitive Impairment.

Authors:  Byoung Seok Ye; Eun Young Jang; Seong Yoon Kim; Eun-Joo Kim; Sun Ah Park; Yunhwan Lee; Chang Hyung Hong; Seong Hye Choi; Bora Yoon; Soo Jin Yoon; Hae Ri Na; Jae-Hong Lee; Jee H Jeong; Hee Jin Kim; Duk L Na; Sang Won Seo
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 4.  Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies.

Authors:  K J Anstey; N Cherbuin; M Budge; J Young
Journal:  Obes Rev       Date:  2011-02-23       Impact factor: 9.213

5.  15-year longitudinal study of blood pressure and dementia.

Authors:  I Skoog; B Lernfelt; S Landahl; B Palmertz; L A Andreasson; L Nilsson; G Persson; A Odén; A Svanborg
Journal:  Lancet       Date:  1996-04-27       Impact factor: 79.321

6.  Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study.

Authors:  Rachel A Whitmer; Erica P Gunderson; Elizabeth Barrett-Connor; Charles P Quesenberry; Kristine Yaffe
Journal:  BMJ       Date:  2005-04-29

7.  The 32-year relationship between cholesterol and dementia from midlife to late life.

Authors:  M M Mielke; P P Zandi; H Shao; M Waern; S Östling; X Guo; C Björkelund; L Lissner; I Skoog; D R Gustafson
Journal:  Neurology       Date:  2010-11-10       Impact factor: 9.910

8.  Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke.

Authors:  Michael Böhm; Daniel Cotton; Lydia Foster; Florian Custodis; Ulrich Laufs; Ralph Sacco; Philip M W Bath; Salim Yusuf; Hans-Christoph Diener
Journal:  Eur Heart J       Date:  2012-08-26       Impact factor: 29.983

9.  Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease.

Authors:  P V Arriagada; K Marzloff; B T Hyman
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

10.  Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort.

Authors:  Anna-Maija Tolppanen; Tiia Ngandu; Ingemar Kåreholt; Tiina Laatikainen; Minna Rusanen; Hilkka Soininen; Miia Kivipelto
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

View more
  11 in total

1.  A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology.

Authors:  Michael L Alosco; Michael A Sugarman; Lilah M Besser; Yorghos Tripodis; Brett Martin; Joseph N Palmisano; Neil W Kowall; Rhoda Au; Jesse Mez; Charles DeCarli; Thor D Stein; Ann C McKee; Ronald J Killiany; Robert A Stern
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

2.  Failure to detect an association between self-reported traumatic brain injury and Alzheimer's disease neuropathology and dementia.

Authors:  Michael A Sugarman; Ann C McKee; Thor D Stein; Yorghos Tripodis; Lilah M Besser; Brett Martin; Joseph N Palmisano; Eric G Steinberg; Maureen K O'Connor; Rhoda Au; Michael McClean; Ronald Killiany; Jesse Mez; Michael W Weiner; Neil W Kowall; Robert A Stern; Michael L Alosco
Journal:  Alzheimers Dement       Date:  2019-03-07       Impact factor: 21.566

3.  The Association Between Body Mass Index, and Cognitive, Functional, and Behavioral Declines for Incident Dementia.

Authors:  Tzeyu L Michaud; Mohammad Siahpush; Paraskevi A Farazi; Jungyoon Kim; Fang Yu; Dejun Su; Daniel L Murman
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

4.  Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set.

Authors:  Michael L Alosco; Jonathan Duskin; Lilah M Besser; Brett Martin; Christine E Chaisson; John Gunstad; Neil W Kowall; Ann C McKee; Robert A Stern; Yorghos Tripodis
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease.

Authors:  Isabelle Bos; Stephanie J B Vos; Suzanne E Schindler; Jason Hassenstab; Chengjie Xiong; Elizabeth Grant; Frans Verhey; John C Morris; Pieter Jelle Visser; Anne M Fagan
Journal:  Alzheimers Dement       Date:  2019-08-01       Impact factor: 21.566

6.  CSF biomarkers in Olmsted County: Evidence of 2 subclasses and associations with demographics.

Authors:  Argonde C Van Harten; Heather J Wiste; Stephen D Weigand; Michelle M Mielke; Walter K Kremers; Udo Eichenlaub; Richard Batrla-Utermann; Roy B Dyer; Alicia Algeciras-Schimnich; David S Knopman; Clifford R Jack; Ronald C Petersen
Journal:  Neurology       Date:  2020-06-26       Impact factor: 9.910

Review 7.  Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease.

Authors:  Anders Wallin; Gustavo C Román; Margaret Esiri; Petronella Kettunen; Johan Svensson; George P Paraskevas; Elisabeth Kapaki
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  "Exceptional brain aging" without Alzheimer's disease: triggers, accelerators, and the net sum game.

Authors:  Prashanthi Vemuri
Journal:  Alzheimers Res Ther       Date:  2018-06-01       Impact factor: 6.982

9.  Association between Peripheral Leptin and Adiponectin Levels and Cognitive Decline in Patients with Neurocognitive Disorders ≥65 Years.

Authors:  Thomas Gilbert; Sylvain Roche; Emilie Blond; Jean-Yves Bar; Jocelyne Drai; Charlotte Cuerq; Marine Haution-Bitker; René Ecochard; Marc Bonnefoy
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

10.  Cerebrovascular pathology in Down syndrome and Alzheimer disease.

Authors:  Elizabeth Head; Michael J Phelan; Eric Doran; Ronald C Kim; Wayne W Poon; Frederick A Schmitt; Ira T Lott
Journal:  Acta Neuropathol Commun       Date:  2017-12-01       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.